EUVIMEDEUVIMED entdecken
Fallbericht

DPYD genotype should be extended to rare variants: report on two cases of phenotype / genotype discrepancy

Paul Vilquin, Yves Medard, Fabienne Thomas, Lauriane Goldwirt, Luis Teixeira, Samia Mourah, Evelyne Jacqz-Aigrain iD

Cancer Chemotherapy and Pharmacology · 2025

DOI: 10.1007/s00280-024-04738-5 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Paul Vilquin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de Génomique des Tumeurs et Pharmacologie, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France. Hauptthemen laut MEDLINE: Dihydrouracil Dehydrogenase (NADP), Genotype, Phenotype, Fluorouracil. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dihydrouracil Dehydrogenase (NADP)GenotypePhenotypeFluorouracilCapecitabineDihydropyrimidine Dehydrogenase DeficiencyHumansMaleMiddle AgedAntimetabolites, AntineoplasticFemaleAged

Stichwörter der Autor:innen

(3–10): dihydropyrimidine dehydrogenasegene sequencinggenotypepharmacogenephenotyperare varianturacil

Substanzen

Dihydrouracil Dehydrogenase (NADP)FluorouracilCapecitabineAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Service de Génomique des Tumeurs et Pharmacologie, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France.
  • INSERM UMRS 976, Paris, France.
  • Oncopole Claudius Regaud, Institut Universitaire du Cancer and Centre de Recherche en Cancérologie de Toulouse, Toulouse, France.
  • University of Toulouse, Inserm, Toulouse, France.
  • Service de Sénologie, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Sénopôle Territoire Cancer Nord, Toulouse, France.
  • Université Paris Cité, Paris, France.

ORCID-Profile: Evelyne Jacqz-Aigrain

Zitieren

APA

Vilquin, P., Medard, Y., Thomas, F., Goldwirt, L., Teixeira, L., Mourah, S., & Jacqz-Aigrain, E. (2025). DPYD genotype should be extended to rare variants: report on two cases of phenotype / genotype discrepancy. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04738-5

Vancouver

Vilquin P, Medard Y, Thomas F, Goldwirt L, Teixeira L, Mourah S, et al. DPYD genotype should be extended to rare variants: report on two cases of phenotype / genotype discrepancy. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-024-04738-5

BibTeX
@article{Vilquin2025,
  author = {Vilquin, Paul and Medard, Yves and Thomas, Fabienne and Goldwirt, Lauriane and Teixeira, Luis and Mourah, Samia and Jacqz-Aigrain, Evelyne},
  title = {DPYD genotype should be extended to rare variants: report on two cases of phenotype / genotype discrepancy},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  doi = {10.1007/s00280-024-04738-5}
}
Kostenlos starten →